Award

National Heart, Lung, and Blood Institute 3R00HL157552-05S1

Tailored siRNA delivery to human endothelium to inhibit and reverse inflammatory damage following ischemia reperfusion injury in the kidney

Recipient

Villanova University

Award Amount

$58,434.00

Ceiling

$58,434.00

Awarded

August 30, 2024

Identifier

3R00HL157552-05S1

The award funds research to develop polymeric nanoparticle-based siRNA delivery targeting endothelial cells to reduce ischemia reperfusion injury in kidney transplants, involving nanoparticle design, 3D model testing, and in vivo hydrogel delivery.

Description

This project aims to develop a multi-faceted therapeutic strategy to reduce ischemia reperfusion injury related damage to the endothelium of transplanted kidneys. The approach involves using polymeric nanoparticles to deliver siRNA directly to endothelial cells, targeting inflammation and capillary network damage. The project includes designing and characterizing nanoparticles, testing in 3D human vasculature models, and applying delivery within a hydrogel to the renal cortex in vivo.

View original record